Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Inhaled Furosemide Versus Placebo for Acute Viral Bronchiolitis in Hospitalized Infants

This study has been completed.
Information provided by:
Bnai Zion Medical Center Identifier:
First received: December 5, 2005
Last updated: February 5, 2013
Last verified: December 2005
We hypothesize that inhaled Furosemide will be an effective treatment in infants with acute bronchiolitis.

Condition Intervention Phase
Drug: Inhaled Furosemide vs Placebo (Normal Saline)
Phase 1

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Treatment
Official Title: Inhaled Furosemide Versus Placebo for Acute Viral Bronchiolitis in Hospitalized Infants

Resource links provided by NLM:

Further study details as provided by Bnai Zion Medical Center:

Primary Outcome Measures:
  • Clinical respiratory effects

Secondary Outcome Measures:
  • 1. The duration of hospitalization
  • 2. Time weaned off oxygen
  • 3. Time to full enteral feeding

Study Start Date: December 2005
Study Completion Date: April 2006

Ages Eligible for Study:   up to 12 Months   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Age: 0-12 months.
  • Infants who are otherwise healthy
  • Infants with chronic lung disease of prematurity (BPD) will be included, but will be analyzed separately.
  • Parents signed a written informed consent.

Exclusion Criteria:

  • • Other previous or co-morbidity, specifically: respiratory (other than BPD, like Asthma or Cystic Fibrosis), cardiac or renal disease or anomaly.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00261937

Bnai Zion Medical Center and Naharia Galilli Medical Center
Haifa, Israel, 31048
Sponsors and Collaborators
Bnai Zion Medical Center
Principal Investigator: Amir Kugelman Bnai Zion Medical Center
  More Information

Publications: Identifier: NCT00261937     History of Changes
Other Study ID Numbers: 67/05
Study First Received: December 5, 2005
Last Updated: February 5, 2013

Additional relevant MeSH terms:
Bronchiolitis, Viral
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Tract Infections
Virus Diseases
Natriuretic Agents
Physiological Effects of Drugs
Sodium Potassium Chloride Symporter Inhibitors
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action processed this record on May 25, 2017